Calendar Silence Therapeutics plc OTC Markets

Equities

SLNCF

GB00B9GTXM62

Market Closed - OTC Markets 12:20:48 2024-04-18 pm EDT 5-day change 1st Jan Change
8 USD 0.00% Intraday chart for Silence Therapeutics plc 0.00% +433.33%

Chart calendar Silence Therapeutics plc

cf442d408853.azqTl0ZeAAjI2G7U53A-TxrgOSyKxvFy5l-xOb1YGmo.EwzdxBUmUWCQvyHknTZsLVmVQ2bci7oFpTHXAM8ecUciA6X5AxN2Ja7sWg~14d60471231919b2f250fc29eff5398c

Upcoming events on Silence Therapeutics plc

2024-05-13 Q1 2024 Earnings Release (Projected)
2024-09-11 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-03-11 Q4 2024 Earnings Release (Projected)

Past events on Silence Therapeutics plc

2024-03-13 08:00 am Q4 2023 Earnings Call
2024-03-13 07:05 am Q4 2023 Earnings Release
2024-02-07 01:30 pm Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat
2023-11-15 11:30 am Jefferies London Healthcare Conference
2023-11-14 07:00 am Q3 2023 Earnings Release
2023-10-03 08:00 am Chardan Genetic Medicines Conference
2023-09-27 04:10 pm Cantor Global Healthcare Conference
2023-09-12 10:00 am H.C. Wainwright Global Investment Conference
2023-09-11 09:20 am Morgan Stanley Global Healthcare Conference
2023-08-16 07:00 am Q2 2023 Earnings Release
2023-06-07 04:00 pm Jefferies Global Healthcare Conference
2023-05-16 04:00 pm Q1 2023 Earnings Release
2023-05-02 03:30 pm H.C. Wainwright BioConnect Investor Conference
2023-04-27 11:00 am Annual General Meeting
2023-04-04 02:10 pm Guggenheim Genomic Medicines and Rare Disease Day - Fireside Chat
2023-03-15 08:00 am Q4 2022 Earnings Call
2023-03-15 07:00 am Q4 2022 Earnings Release
2023-02-15 03:00 pm SVB Securities Global Biopharma Conference
2023-01-12 12:45 pm JP Morgan Healthcare Conference
2022-11-16 03:00 am Jefferies London Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million GBP
Released
Forecast
Spread
0,24
1,83
-86.63%
5,48
6,35
-13.73%
12,4
13,5
-8.22%
17,5
23,7
-26.26%
25,4
29,0
-12.5%

22,2

EBITDA
Million GBP
Released
Forecast
Spread
-22,3
-18,1
-23.14%
-35,4
-23,2
-52.24%
-45,4
-39,3
-15.49%
-48,1
0,00
-
0,00
-54,9
-

-60,5

EBIT
Million GBP
Released
Forecast
Spread
-22,7
-17,6
-28.86%
-35,8
-26,8
-33.59%
-45,8
-44,5
-3.06%
-48,6
-42,7
-13.87%
-49,6
-46,4
-6.93%

-53,0

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
-22,9
-18,0
-27.1%
-36,0
-26,7
-34.74%
-45,9
-45,8
-0.04%
-47,4
-39,9
-18.69%
-50,3
-41,6
-20.8%

-50,2

Net income
Million GBP
Released
Forecast
Spread
-19,6
-14,8
-32.06%
-32,5
-22,5
-44.97%
-39,4
-42,8
7.83%
-40,5
-33,0
-22.69%
-43,3
-34,4
-25.95%

-42,7

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
-1,64
-1,35
-21.64%
-1,74
-2,36
26.27%
-1,53
-1,55
1.54%
-1,49
-0,86
-73.74%

-0,47

Announcement Date14/04/2030/03/2117/03/2215/03/2313/03/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2020 S2 2021 S1 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million GBP
Released
Forecast
Spread
1,15
1,80
-36.33%
4,33
1,18
266.58%
5,85
2,17
169.79%
3,41
3,90
-12.52%
6,57
6,72
-2.26%
5,72
0,00
-
3,64
2,04
78.58%
9,37
9,53
-1.7%
3,37
1,50
124.73%
4,77
16,8
-71.55%
8,14
11,2
-27.6%
11,4
2,50
354.96%
9,10
3,07
196.87%
2,80
2,40
16.58%
2,10
9,20
-77.18%

3,55


13,1


3,50


3,50


1,90

EBITDA
Million GBP
Released
Forecast
Spread
-14,0
-18,3
23.61%



-22,0








-9,21


-14,0





-13,5



































EBIT
Million GBP
Released
Forecast
Spread
-14,2
-18,3
22.44%
-21,7
-20,3
-6.86%
-22,3
-21,7
-2.58%
-11,3
-10,8
-3.84%
-23,5
-24,7
4.7%
-9,92
-15,0
33.85%
-14,1
-13,9
-1.58%
-24,0
-23,1
-3.83%
-13,6
-15,2
10.66%
-11,0
-0,08
-13026.95%
-24,6
-28,6
14.08%
-12,1
-14,0
13.07%
-11,5
-16,3
29.54%
-12,7
-16,5
23.15%
-13,3
-6,28
-111.92%

-12,5


-5,60


-14,7


-15,8




Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
-13,3
-18,3
27.16%
-22,7
-20,0
-13.62%
-22,6
-22,2
-1.54%
-11,2
-10,8
-3.81%
-23,3
-25,0
6.95%
-9,57
-15,0
36.19%
-13,4
-13,7
2.04%
-23,0
-22,9
-0.59%
-9,33
-15,1
38.21%
-15,1
-2,26
-564.75%
-24,4
-27,6
11.65%
-12,7
-13,9
8.74%
-12,0
-16,2
25.9%
-10,7
-16,5
35.32%
-15,0
-6,28
-138.48%

-12,5


-5,60


-14,7


-15,8




Net income
Million GBP
Released
Forecast
Spread
-11,0
-16,8
34.35%
-21,5
-17,7
-21.89%
-20,0
-20,9
4.03%
-9,43
-9,85
4.26%
-19,4
-27,5
29.71%
-7,68
-13,1
41.43%
-11,9
-12,4
3.54%
-19,6
-26,8
26.71%
-7,10
-13,7
47.99%
-20,6
-0,82
-2428.11%
-27,7
-24,2
-14.54%
-10,2
-12,5
18.57%
-10,4
-15,1
31.01%
-8,25
-15,2
45.75%
-14,4
-5,48
-163.21%

-2,90


-4,00


-13,1


-14,2




EPS
USD
Released
Forecast
Spread



-1,07
-0,81
-31.98%
-0,95
-0,96
1.54%



-0,85
-1,24
31.56%



-0,49


-0,80
-1,09
26.39%



-0,48


-0,73
-0,79
8.08%
-0,36


-0,37
-0,67
45.26%
-0,27
-0,59
53.62%
-0,48
-0,20
-139.24%

-0,08


-0,06


-0,12


-0,13


-0,14

Announcement Date14/09/2030/03/2112/08/2117/03/2217/03/2216/05/2211/08/2211/08/2210/11/2215/03/2315/03/2316/05/2316/08/2314/11/2313/03/24-----

Past sector events for Silence Therapeutics plc

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SLN Stock
  4. SLNCF Stock
  5. Calendar Silence Therapeutics plc